 | • レポートコード：MRC2312MG01638 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥468,000 (USD3,250) | ▷ お問い合わせ |
| Multi User | ￥608,400 (USD4,225) | ▷ お問い合わせ |
| Enterprise User | ￥702,000 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Global Thrombosis and Hemostasis Biomarkers Market 調査レポートは次の情報を含め、グローバルにおけるの血栓＆止血バイオマーカー市場規模と予測を収録しています。 ・世界の血栓＆止血バイオマーカー市場：売上、2018年-2023年、2024年-2029年 ・世界の血栓＆止血バイオマーカー市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の血栓＆止血バイオマーカー市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「分析機器」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。 血栓＆止血バイオマーカーのグローバル主要企業は、BioMérieux SA、 Roche Holding AG、 Biomedica Diagnostics、 Siemens Healthineers、 Abbott、 HORIBA Ltd.、 Werfen、 Quidel Corporation、 Diazyme Laboratories, Inc.、 Thermo Fisher Scientific, Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル社は、血栓＆止血バイオマーカーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別マーケット分析】 世界の血栓＆止血バイオマーカー市場：タイプ別、2018年-2023年、2024年-2029年 世界の血栓＆止血バイオマーカー市場：タイプ別市場シェア、2022年 ・分析機器、試薬、消耗品、その他 世界の血栓＆止血バイオマーカー市場：用途別、2018年-2023年、2024年-2029年 世界の血栓＆止血バイオマーカー市場：用途別市場シェア、2022年 ・診療所、病院、研究所、その他 世界の血栓＆止血バイオマーカー市場：地域・国別、2018年-2023年、2024年-2029年 世界の血栓＆止血バイオマーカー市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競争分析】 また、当レポートは主要な参入企業の分析を提供します。 ・主要企業における血栓＆止血バイオマーカーのグローバル売上、2018年-2023年 ・主要企業における血栓＆止血バイオマーカーのグローバル売上シェア、2022年 ・主要企業における血栓＆止血バイオマーカーのグローバル販売量、2018年-2023年 ・主要企業における血栓＆止血バイオマーカーのグローバル販売量シェア、2022年 さらに、当レポートは主要企業の情報を提示します。 BioMérieux SA、 Roche Holding AG、 Biomedica Diagnostics、 Siemens Healthineers、 Abbott、 HORIBA Ltd.、 Werfen、 Quidel Corporation、 Diazyme Laboratories, Inc.、 Thermo Fisher Scientific, Inc. ************************************************************* ・調査・分析レポートの概要 血栓＆止血バイオマーカー市場の定義 市場セグメント 世界の血栓＆止血バイオマーカー市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の血栓＆止血バイオマーカー市場規模 世界の血栓＆止血バイオマーカー市場規模：2022年 VS 2029年 世界の血栓＆止血バイオマーカー市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの血栓＆止血バイオマーカーの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の血栓＆止血バイオマーカー製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：分析機器、試薬、消耗品、その他 血栓＆止血バイオマーカーのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：診療所、病院、研究所、その他 血栓＆止血バイオマーカーの用途別グローバル売上・予測 ・地域別市場分析 地域別血栓＆止血バイオマーカー市場規模 2022年と2029年 地域別血栓＆止血バイオマーカー売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど） BioMérieux SA、 Roche Holding AG、 Biomedica Diagnostics、 Siemens Healthineers、 Abbott、 HORIBA Ltd.、 Werfen、 Quidel Corporation、 Diazyme Laboratories, Inc.、 Thermo Fisher Scientific, Inc. ... |
This research report provides a comprehensive analysis of the Thrombosis and Hemostasis Biomarkers market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Thrombosis and Hemostasis Biomarkers market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Thrombosis and Hemostasis Biomarkers, challenges faced by the industry, and potential opportunities for market players.
The global Thrombosis and Hemostasis Biomarkers market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Thrombosis and Hemostasis Biomarkers market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Thrombosis and Hemostasis Biomarkers market. Additionally, the growing consumer demand present avenues for market expansion.
The global Thrombosis and Hemostasis Biomarkers market was valued at US$ 4715.9 million in 2022 and is projected to reach US$ 7219.2 million by 2029, at a CAGR of 6.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Thrombosis and Hemostasis Biomarkers market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Thrombosis and Hemostasis Biomarkers market.
Market Overview: The report provides a comprehensive overview of the Thrombosis and Hemostasis Biomarkers market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Analysers, Reagents), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Thrombosis and Hemostasis Biomarkers market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Thrombosis and Hemostasis Biomarkers market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Thrombosis and Hemostasis Biomarkers market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Thrombosis and Hemostasis Biomarkers market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Thrombosis and Hemostasis Biomarkers market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Thrombosis and Hemostasis Biomarkers market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Thrombosis and Hemostasis Biomarkers, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Thrombosis and Hemostasis Biomarkers market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Thrombosis and Hemostasis Biomarkers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Analysers
Reagents
Consumables
Others
Market segment by Application
Clinic
Hospital
Research Institute
Others
Global Thrombosis and Hemostasis Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
BioMérieux SA
Roche Holding AG
Biomedica Diagnostics
Siemens Healthineers
Abbott
HORIBA Ltd.
Werfen
Quidel Corporation
Diazyme Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thrombosis and Hemostasis Biomarkers, market overview.
Chapter 2: Global Thrombosis and Hemostasis Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Thrombosis and Hemostasis Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thrombosis and Hemostasis Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Thrombosis and Hemostasis Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Thrombosis and Hemostasis Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thrombosis and Hemostasis Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thrombosis and Hemostasis Biomarkers Overall Market Size
2.1 Global Thrombosis and Hemostasis Biomarkers Market Size: 2022 VS 2029
2.2 Global Thrombosis and Hemostasis Biomarkers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Thrombosis and Hemostasis Biomarkers Sales: 2018-2029
3 Company Landscape
3.1 Top Thrombosis and Hemostasis Biomarkers Players in Global Market
3.2 Top Global Thrombosis and Hemostasis Biomarkers Companies Ranked by Revenue
3.3 Global Thrombosis and Hemostasis Biomarkers Revenue by Companies
3.4 Global Thrombosis and Hemostasis Biomarkers Sales by Companies
3.5 Global Thrombosis and Hemostasis Biomarkers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Thrombosis and Hemostasis Biomarkers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Thrombosis and Hemostasis Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Thrombosis and Hemostasis Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Thrombosis and Hemostasis Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Thrombosis and Hemostasis Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Thrombosis and Hemostasis Biomarkers Market Size Markets, 2022 & 2029
4.1.2 Analysers
4.1.3 Reagents
4.1.4 Consumables
4.1.5 Others
4.2 By Type – Global Thrombosis and Hemostasis Biomarkers Revenue & Forecasts
4.2.1 By Type – Global Thrombosis and Hemostasis Biomarkers Revenue, 2018-2023
4.2.2 By Type – Global Thrombosis and Hemostasis Biomarkers Revenue, 2024-2029
4.2.3 By Type – Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
4.3 By Type – Global Thrombosis and Hemostasis Biomarkers Sales & Forecasts
4.3.1 By Type – Global Thrombosis and Hemostasis Biomarkers Sales, 2018-2023
4.3.2 By Type – Global Thrombosis and Hemostasis Biomarkers Sales, 2024-2029
4.3.3 By Type – Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
4.4 By Type – Global Thrombosis and Hemostasis Biomarkers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Thrombosis and Hemostasis Biomarkers Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Research Institute
5.1.5 Others
5.2 By Application – Global Thrombosis and Hemostasis Biomarkers Revenue & Forecasts
5.2.1 By Application – Global Thrombosis and Hemostasis Biomarkers Revenue, 2018-2023
5.2.2 By Application – Global Thrombosis and Hemostasis Biomarkers Revenue, 2024-2029
5.2.3 By Application – Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
5.3 By Application – Global Thrombosis and Hemostasis Biomarkers Sales & Forecasts
5.3.1 By Application – Global Thrombosis and Hemostasis Biomarkers Sales, 2018-2023
5.3.2 By Application – Global Thrombosis and Hemostasis Biomarkers Sales, 2024-2029
5.3.3 By Application – Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
5.4 By Application – Global Thrombosis and Hemostasis Biomarkers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Thrombosis and Hemostasis Biomarkers Market Size, 2022 & 2029
6.2 By Region – Global Thrombosis and Hemostasis Biomarkers Revenue & Forecasts
6.2.1 By Region – Global Thrombosis and Hemostasis Biomarkers Revenue, 2018-2023
6.2.2 By Region – Global Thrombosis and Hemostasis Biomarkers Revenue, 2024-2029
6.2.3 By Region – Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
6.3 By Region – Global Thrombosis and Hemostasis Biomarkers Sales & Forecasts
6.3.1 By Region – Global Thrombosis and Hemostasis Biomarkers Sales, 2018-2023
6.3.2 By Region – Global Thrombosis and Hemostasis Biomarkers Sales, 2024-2029
6.3.3 By Region – Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029
6.4.2 By Country – North America Thrombosis and Hemostasis Biomarkers Sales, 2018-2029
6.4.3 US Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.4.4 Canada Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.4.5 Mexico Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029
6.5.2 By Country – Europe Thrombosis and Hemostasis Biomarkers Sales, 2018-2029
6.5.3 Germany Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.4 France Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.5 U.K. Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.6 Italy Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.7 Russia Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.8 Nordic Countries Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.5.9 Benelux Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029
6.6.2 By Region – Asia Thrombosis and Hemostasis Biomarkers Sales, 2018-2029
6.6.3 China Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.6.4 Japan Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.6.5 South Korea Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.6.6 Southeast Asia Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.6.7 India Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029
6.7.2 By Country – South America Thrombosis and Hemostasis Biomarkers Sales, 2018-2029
6.7.3 Brazil Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.7.4 Argentina Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Thrombosis and Hemostasis Biomarkers Sales, 2018-2029
6.8.3 Turkey Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.8.4 Israel Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.8.5 Saudi Arabia Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
6.8.6 UAE Thrombosis and Hemostasis Biomarkers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BioMérieux SA
7.1.1 BioMérieux SA Company Summary
7.1.2 BioMérieux SA Business Overview
7.1.3 BioMérieux SA Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.1.4 BioMérieux SA Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.1.5 BioMérieux SA Key News & Latest Developments
7.2 Roche Holding AG
7.2.1 Roche Holding AG Company Summary
7.2.2 Roche Holding AG Business Overview
7.2.3 Roche Holding AG Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.2.4 Roche Holding AG Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.2.5 Roche Holding AG Key News & Latest Developments
7.3 Biomedica Diagnostics
7.3.1 Biomedica Diagnostics Company Summary
7.3.2 Biomedica Diagnostics Business Overview
7.3.3 Biomedica Diagnostics Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.3.4 Biomedica Diagnostics Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.3.5 Biomedica Diagnostics Key News & Latest Developments
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Company Summary
7.4.2 Siemens Healthineers Business Overview
7.4.3 Siemens Healthineers Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.4.4 Siemens Healthineers Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.4.5 Siemens Healthineers Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.5.4 Abbott Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 HORIBA Ltd.
7.6.1 HORIBA Ltd. Company Summary
7.6.2 HORIBA Ltd. Business Overview
7.6.3 HORIBA Ltd. Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.6.4 HORIBA Ltd. Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.6.5 HORIBA Ltd. Key News & Latest Developments
7.7 Werfen
7.7.1 Werfen Company Summary
7.7.2 Werfen Business Overview
7.7.3 Werfen Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.7.4 Werfen Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.7.5 Werfen Key News & Latest Developments
7.8 Quidel Corporation
7.8.1 Quidel Corporation Company Summary
7.8.2 Quidel Corporation Business Overview
7.8.3 Quidel Corporation Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.8.4 Quidel Corporation Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.8.5 Quidel Corporation Key News & Latest Developments
7.9 Diazyme Laboratories, Inc.
7.9.1 Diazyme Laboratories, Inc. Company Summary
7.9.2 Diazyme Laboratories, Inc. Business Overview
7.9.3 Diazyme Laboratories, Inc. Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.9.4 Diazyme Laboratories, Inc. Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.9.5 Diazyme Laboratories, Inc. Key News & Latest Developments
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Thermo Fisher Scientific, Inc. Company Summary
7.10.2 Thermo Fisher Scientific, Inc. Business Overview
7.10.3 Thermo Fisher Scientific, Inc. Thrombosis and Hemostasis Biomarkers Major Product Offerings
7.10.4 Thermo Fisher Scientific, Inc. Thrombosis and Hemostasis Biomarkers Sales and Revenue in Global (2018-2023)
7.10.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
8 Global Thrombosis and Hemostasis Biomarkers Production Capacity, Analysis
8.1 Global Thrombosis and Hemostasis Biomarkers Production Capacity, 2018-2029
8.2 Thrombosis and Hemostasis Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Thrombosis and Hemostasis Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Thrombosis and Hemostasis Biomarkers Supply Chain Analysis
10.1 Thrombosis and Hemostasis Biomarkers Industry Value Chain
10.2 Thrombosis and Hemostasis Biomarkers Upstream Market
10.3 Thrombosis and Hemostasis Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Thrombosis and Hemostasis Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Thrombosis and Hemostasis Biomarkers in Global Market
Table 2. Top Thrombosis and Hemostasis Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Thrombosis and Hemostasis Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Thrombosis and Hemostasis Biomarkers Revenue Share by Companies, 2018-2023
Table 5. Global Thrombosis and Hemostasis Biomarkers Sales by Companies, (K Units), 2018-2023
Table 6. Global Thrombosis and Hemostasis Biomarkers Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Thrombosis and Hemostasis Biomarkers Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Thrombosis and Hemostasis Biomarkers Product Type
Table 9. List of Global Tier 1 Thrombosis and Hemostasis Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thrombosis and Hemostasis Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2018-2023
Table 15. By Type - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2024-2029
Table 16. By Application – Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2018-2023
Table 20. By Application - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2024-2029
Table 21. By Region – Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Thrombosis and Hemostasis Biomarkers Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2018-2023
Table 25. By Region - Global Thrombosis and Hemostasis Biomarkers Sales (K Units), 2024-2029
Table 26. By Country - North America Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2018-2023
Table 29. By Country - North America Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2024-2029
Table 30. By Country - Europe Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2018-2023
Table 33. By Country - Europe Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2024-2029
Table 34. By Region - Asia Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2018-2023
Table 37. By Region - Asia Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2024-2029
Table 38. By Country - South America Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2018-2023
Table 41. By Country - South America Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Sales, (K Units), 2024-2029
Table 46. BioMérieux SA Company Summary
Table 47. BioMérieux SA Thrombosis and Hemostasis Biomarkers Product Offerings
Table 48. BioMérieux SA Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. BioMérieux SA Key News & Latest Developments
Table 50. Roche Holding AG Company Summary
Table 51. Roche Holding AG Thrombosis and Hemostasis Biomarkers Product Offerings
Table 52. Roche Holding AG Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Roche Holding AG Key News & Latest Developments
Table 54. Biomedica Diagnostics Company Summary
Table 55. Biomedica Diagnostics Thrombosis and Hemostasis Biomarkers Product Offerings
Table 56. Biomedica Diagnostics Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Biomedica Diagnostics Key News & Latest Developments
Table 58. Siemens Healthineers Company Summary
Table 59. Siemens Healthineers Thrombosis and Hemostasis Biomarkers Product Offerings
Table 60. Siemens Healthineers Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Siemens Healthineers Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Thrombosis and Hemostasis Biomarkers Product Offerings
Table 64. Abbott Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Abbott Key News & Latest Developments
Table 66. HORIBA Ltd. Company Summary
Table 67. HORIBA Ltd. Thrombosis and Hemostasis Biomarkers Product Offerings
Table 68. HORIBA Ltd. Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. HORIBA Ltd. Key News & Latest Developments
Table 70. Werfen Company Summary
Table 71. Werfen Thrombosis and Hemostasis Biomarkers Product Offerings
Table 72. Werfen Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Werfen Key News & Latest Developments
Table 74. Quidel Corporation Company Summary
Table 75. Quidel Corporation Thrombosis and Hemostasis Biomarkers Product Offerings
Table 76. Quidel Corporation Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Quidel Corporation Key News & Latest Developments
Table 78. Diazyme Laboratories, Inc. Company Summary
Table 79. Diazyme Laboratories, Inc. Thrombosis and Hemostasis Biomarkers Product Offerings
Table 80. Diazyme Laboratories, Inc. Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Diazyme Laboratories, Inc. Key News & Latest Developments
Table 82. Thermo Fisher Scientific, Inc. Company Summary
Table 83. Thermo Fisher Scientific, Inc. Thrombosis and Hemostasis Biomarkers Product Offerings
Table 84. Thermo Fisher Scientific, Inc. Thrombosis and Hemostasis Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 86. Thrombosis and Hemostasis Biomarkers Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Thrombosis and Hemostasis Biomarkers Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Thrombosis and Hemostasis Biomarkers Production by Region, 2018-2023 (K Units)
Table 89. Global Thrombosis and Hemostasis Biomarkers Production by Region, 2024-2029 (K Units)
Table 90. Thrombosis and Hemostasis Biomarkers Market Opportunities & Trends in Global Market
Table 91. Thrombosis and Hemostasis Biomarkers Market Drivers in Global Market
Table 92. Thrombosis and Hemostasis Biomarkers Market Restraints in Global Market
Table 93. Thrombosis and Hemostasis Biomarkers Raw Materials
Table 94. Thrombosis and Hemostasis Biomarkers Raw Materials Suppliers in Global Market
Table 95. Typical Thrombosis and Hemostasis Biomarkers Downstream
Table 96. Thrombosis and Hemostasis Biomarkers Downstream Clients in Global Market
Table 97. Thrombosis and Hemostasis Biomarkers Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Thrombosis and Hemostasis Biomarkers Segment by Type in 2022
Figure 2. Thrombosis and Hemostasis Biomarkers Segment by Application in 2022
Figure 3. Global Thrombosis and Hemostasis Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Thrombosis and Hemostasis Biomarkers Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Thrombosis and Hemostasis Biomarkers Revenue, 2018-2029 (US$, Mn)
Figure 7. Thrombosis and Hemostasis Biomarkers Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Thrombosis and Hemostasis Biomarkers Revenue in 2022
Figure 9. By Type - Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 11. By Type - Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 12. By Type - Global Thrombosis and Hemostasis Biomarkers Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 15. By Application - Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 16. By Application - Global Thrombosis and Hemostasis Biomarkers Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 20. By Region - Global Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 21. By Country - North America Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 22. By Country - North America Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 23. US Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 28. Germany Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 29. France Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 37. China Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 41. India Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 43. By Country - South America Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 44. Brazil Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Thrombosis and Hemostasis Biomarkers Sales Market Share, 2018-2029
Figure 48. Turkey Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Thrombosis and Hemostasis Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 52. Global Thrombosis and Hemostasis Biomarkers Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Thrombosis and Hemostasis Biomarkers by Region, 2022 VS 2029
Figure 54. Thrombosis and Hemostasis Biomarkers Industry Value Chain
Figure 55. Marketing Channels
• 日本語訳：世界の血栓＆止血バイオマーカー市場予測2023-2029：分析機器、試薬、消耗品、その他
• レポートコード：MRC2312MG01638 ▷ お問い合わせ（見積依頼・ご注文・質問）